Inventor
Max Hasmann
Inventor
Neuried, DE
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
C07KPeptides6%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
9,687,568'Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label'20179,180,185'Combination therapy of anti-HER3 antibodies'20159,090,700'Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2'20158,529,901'Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label'20137,320,993'Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents'20087,276,524'Pyridyl alkane acid amides as cytostatics and immunosuppressives'20077,241,745'Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives'20077,192,967'Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents'20076,903,118'Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides'20056,593,344'Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides'20036,506,572'Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy'20036,451,816'Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression'20026,444,823'Pyridyl alkane acid amides as cytostatics and immunosuppressives'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2005Patents assigned to KLINGE CO CHEM PHARM FAB (5)· patent assignee history
2002–2008Based in Neuried, DE· patent location history
2007–2008Patents assigned to ASTELLAS DEUTSCHLAND GMBH (2)· patent assignee history
2007Patents assigned to ASTELLAS PHARMA GMBH (2)· patent assignee history
2013–2017Patents assigned to HOFFMANN LA ROCHE (4)· patent assignee history
2013–2015Patents assigned to HASMANN MAX (2)· patent assignee history
2013–2017Based in Munich, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KLINGE CO CHEM PHARM FAB | 5 | 2002–2005 |
| HOFFMANN LA ROCHE | 4 | 2013–2017 |
| ASTELLAS DEUTSCHLAND GMBH | 2 | 2007–2008 |
| ASTELLAS PHARMA GMBH | 2 | 2007 |
| HASMANN MAXself | 2 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Neuried, DE | 9 | 2002–2008 |
| Munich, DE | 4 | 2013–2017 |